BACKGROUND AND PURPOSE: Intraoperative MR imaging (IMRI) has advantages over conventional framed and frameless techniques. IMRI, however, also has some drawbacks, especially related to interpretation of gadolinium-enhanced intraoperative imaging resulting from surgically induced blood brain barrier injury, vascular changes, and hemorrhage. Ultra-small superparamagnetic iron particles like ferumoxtran-10 have a long plasma half-life and are trapped by reactive cells within the tumor. These trapped particles provide a method to demonstrate enhancing lesions without the artifact of repeat gadolinium administration in the face of blood brain barrier and vascular injury. METHODS: We present a review of the literature and the cases of two patients who underwent surgery in which IMRI with ferumoxtran-10 was used. RESULTS: Ultra-small superparamagnetic iron particles represent a method to demonstrate enhancing intrinsic brain tumors without the drawbacks of intraoperative gadolinium enhancement. These lesions appear even on low-field strength IMRI. Ferumoxtran-10, administered preoperatively, provides a stable imaging marker, even after surgical manipulation of the brain. CONCLUSION: Fermumoxtran-10 provides a way to lessen artifactual enhancement during IMRI related to the administration of gadolinium.
BACKGROUND AND PURPOSE: Intraoperative MR imaging (IMRI) has advantages over conventional framed and frameless techniques. IMRI, however, also has some drawbacks, especially related to interpretation of gadolinium-enhanced intraoperative imaging resulting from surgically induced blood brain barrier injury, vascular changes, and hemorrhage. Ultra-small superparamagnetic iron particles like ferumoxtran-10 have a long plasma half-life and are trapped by reactive cells within the tumor. These trapped particles provide a method to demonstrate enhancing lesions without the artifact of repeat gadolinium administration in the face of blood brain barrier and vascular injury. METHODS: We present a review of the literature and the cases of two patients who underwent surgery in which IMRI with ferumoxtran-10 was used. RESULTS: Ultra-small superparamagnetic iron particles represent a method to demonstrate enhancing intrinsic brain tumors without the drawbacks of intraoperative gadolinium enhancement. These lesions appear even on low-field strength IMRI. Ferumoxtran-10, administered preoperatively, provides a stable imaging marker, even after surgical manipulation of the brain. CONCLUSION:Fermumoxtran-10 provides a way to lessen artifactual enhancement during IMRI related to the administration of gadolinium.
Authors: Peter Varallyay; Gary Nesbit; Leslie L Muldoon; Randal R Nixon; Johnny Delashaw; James I Cohen; Annie Petrillo; Doris Rink; Edward A Neuwelt Journal: AJNR Am J Neuroradiol Date: 2002-04 Impact factor: 3.825
Authors: Edit Dósa; Suchita Tuladhar; Leslie L Muldoon; Bronwyn E Hamilton; William D Rooney; Edward A Neuwelt Journal: Stroke Date: 2011-04-14 Impact factor: 7.914
Authors: Jason S Weinstein; Csanad G Varallyay; Edit Dosa; Seymur Gahramanov; Bronwyn Hamilton; William D Rooney; Leslie L Muldoon; Edward A Neuwelt Journal: J Cereb Blood Flow Metab Date: 2009-09-16 Impact factor: 6.200
Authors: Bronwyn E Hamilton; Gary M Nesbit; Edit Dosa; Seymur Gahramanov; Bill Rooney; Eric G Nesbit; Joshua Raines; Edward A Neuwelt Journal: AJR Am J Roentgenol Date: 2011-10 Impact factor: 3.959
Authors: Sándor P Manninger; Leslie L Muldoon; Gary Nesbit; Tulio Murillo; Paula M Jacobs; Edward A Neuwelt Journal: AJNR Am J Neuroradiol Date: 2005-10 Impact factor: 3.825
Authors: Edward A Neuwelt; Bronwyn E Hamilton; Csanad G Varallyay; William R Rooney; Robert D Edelman; Paula M Jacobs; Suzanne G Watnick Journal: Kidney Int Date: 2008-10-08 Impact factor: 10.612
Authors: Vanja Varenika; Peter Dickinson; John Bringas; Richard LeCouteur; Robert Higgins; John Park; Massimo Fiandaca; Mitchel Berger; John Sampson; Krystof Bankiewicz Journal: J Neurosurg Date: 2008-11 Impact factor: 5.115
Authors: Pieter L Kubben; Pieter Wesseling; Martin Lammens; Olaf E M G Schijns; Mariël P Ter Laak-Poort; Jacobus J van Overbeeke; Henk van Santbrink Journal: Surg Neurol Int Date: 2012-12-26
Authors: Zoe Z Zhang; Lisa B E Shields; David A Sun; Yi Ping Zhang; Matthew A Hunt; Christopher B Shields Journal: Front Oncol Date: 2015-07-30 Impact factor: 6.244